Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease.
Study data show that AdvanceAD-Tx can stratify patients by molecular profile identifying those more likely to achieve near-clear skin (EASI-90), faster time to response and meaningful patient-reported ...
STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of ...
Boca Raton, FL, Feb. 19, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (“INmune” or the “Company”), a late-stage biotechnology company focused on inflammation and immunology, will host a ...
The team distributed 260 parcels alone to the Al-Affad Camp in Northern State. The camp currently hosts over 4,200 households, equating to approximately 25,800 people. In addition to food assistance, ...
At Optum, Williamson held a crucial management position and gained direct experience in architecting an initiative focused on the coordination of medical, behavioral, and social care for individuals ...
In the United States, ONS-5010/LYTENAVA ™ (bevacizumab-vikg) is investigational. In certain European Union Member States ONS-5010/LYTENAVA™ must receive pricing and reimbursement approval before it ...
Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to ...
Company Ready to Scale Growth through OneTest™ AI-Powered Blood Tests for Cancer and Longevity. GAITHERSBURG, Md., Feb. 19, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. (Nasdaq: ...
Cynet, the unified, AI-powered cybersecurity platform empowering organizations to focus on what matters most, has released its 2H 2025 CyOps ECHO Report (Examination of Cyber Hostility and Operations) ...
The live webcast of the presentation may be accessed via the Investors section of the Connect website at investors.connectbiopharma.com. An archived replay of the event will be available on the ...
The ‘Boosting the translation of biotech research into innovative health therapies’ topic, which forms part of the wider Horizon Europe 2025 Health initiative, is designed to accelerate the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results